Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Gene Therapy
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
June 2000, Volume 7, Number 11, Pages 960-966
Table of contents    Previous  Abstract  Next   Full text  PDF
Acquired diseases
Pretreatment with cationic lipid-mediated transfer of the Na+K+-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedema
M Stern1, K Ulrich1, C Robinson1, J Copeland1, U Griesenbach1, C Masse2, S Cheng3, F Munkonge1, D Geddes1, Y Berthiaume2 and E Alton1

1Department of Gene Therapy, Imperial College at the National Heart and Lung Institute, London, UK

2Centre de Recherche, Hôtel-Dieu de Montréal and Department of Medicine, Université de Montréal, Montreal, Quebec, Canada

3Genzyme Corporation, Framingham, MA, USA

Correspondence to: M Stern, Department of Gene Therapy, National Heart and Lung Institute, Manresa Road, London SW3 6LR, UK

Abstract

Resolution of pulmonary oedema is mediated by active absorption of liquid across the alveolar epithelium. A key component of this process is the sodium-potassium ATPase (Na+K+-ATPase) enzyme located on the basolateral surface of epithelial cells and up-regulated during oedema resolution. We hypothesised that lung liquid clearance could be further up-regulated by lipid-mediated transfer and expression of exogenous Na+K+-ATPase cDNA. We demonstrate proof of this principle in a model of high permeability pulmonary oedema induced by intraperitoneal injection of thiourea (2.5 mg/kg) in C57/BL6 mice. Pretreatment of mice (24 h before thiourea) by nasal sniffing of cationic liposome (lipid #67)-DNA complexes encoding the alpha and beta subunits of Na+K+-ATPase (160 mug per mouse), significantly (P < 0.01) decreased the wet:dry weight ratios measured 2 h after thiourea injection compared with control animals, pretreated with an equivalent dose of an irrelevant gene. whole lung na+K+-ATPase activity was significantly (P < 0.05) increased in mice pretreated with na+K+-ATPase cDNA compared both with untreated control animals as well as animals pretreated with the irrelevant gene. Nested RT-PCR on whole lung homogenates confirmed gene transfer by detection of vector-specific mRNA in three of four mice studied 24 h after gene transfer. This demonstration of a significant reduction in pulmonary oedema following in vivo gene transfer raises the possibility of gene therapy as a novel, localised approach for pulmonary oedema in clinical settings such as ARDS and lung transplantation. Gene Therapy (2000) 7, 960-966.

Keywords

gene therapy; Na+K+-ATPase; liposome; pulmonary oedema

Received 8 November 1999; accepted 28 February 2000
June 2000, Volume 7, Number 11, Pages 960-966
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 2000 Nature Publishing Group